We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Purdue Pharmaceuticals announced that it will no longer promote its opioid products to doctors and will cut its sales force by more than half. Read More
Three insurers sued Pfizer to stay off the hook for a $400 million settlement reached by the drugmaker over off-label marketing, claiming the relevant policies had expired. Read More
New York’s attorney general is suing Insys for deceptive marketing of the spray form of one of its fentanyl products, a move the state says is part of a multi-pronged strategy to address the addiction crisis. Read More
Three supermarket chains sued more than 20 generic drug manufacturers, including Actavis, Apotex, Mylan, Teva and Sandoz, alleging they engaged in a conspiracy to set prices. Read More
A Chicago jury found AbbVie not liable for an Arizona man’s pulmonary embolism that he blamed on AndroGel, the company’s testosterone replacement drug. Read More
A federal circuit court upheld a PTO Patent Trial and Appeal Board ruling that a Johnson & Johnson patent for Remicade, which earned the company nearly $7 billion in 2016, is invalid. Read More
A drug research firm is suing the FDA for $50 million, arguing the agency issued a disciplinary letter that “annihilated” the company based on evidence fabricated by a rogue employee. Read More